Adverum Biotechnologies (ADVM) Prices 14.5M Share Common Offering at $13/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Pre-Open Stock Stock Movers 08/12: (PEIX) (MRNA) (TSLA) Higher; (TRVN) (SMCI) (PLUG) Lower (more...)
August 12, 2020 9:25 AM EDTPre-Open Stock Movers:
Pacific Ethanol (NASDAQ: PEIX) 21% HIGHER; reported Q2 EPS of $0.27, versus ($0.17) reported last year. Revenue for the quarter came in at $212.1 million, versus $346.3 million reported last year. Looking at the second half of the year, we expect Adjusted EBITDA to range between $50 and $70 million, with momentum continuing into 2021."
Trevena, Inc. (Nasdaq: TRVN) 16.4% LOWER; intends to offer and sell shares of its common stock in an underwritten public... More
After-Hours Stock Movers 08/11: (MRNA) (TSLA) (AOSL) Higher; (TRVN) (RRGB) (PLUG) Lower (more...)
August 11, 2020 6:12 PM EDTAfter-Hours Stock Movers:
Pacific Ethanol (NASDAQ: PEIX) 21% HIGHER; reported Q2 EPS of $0.27, versus ($0.17) reported last year. Revenue for the quarter came in at $212.1 million, versus $346.3 million reported last year. Looking at the second half of the year, we expect Adjusted EBITDA to range between $50 and $70 million, with momentum continuing into 2021."
Trevena, Inc. (Nasdaq: TRVN) 16.4% LOWER; intends to offer and sell shares of its common stock in an underwritten public offering. In addition,... More
Adverum Biotechnologies (ADVM) Announces $200M Common Share Offering
August 11, 2020 4:02 PM EDTAdverum Biotechnologies, Inc. (NASDAQ: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced that it has commenced an underwritten public offering of $200 million of its common stock. The company intends to grant the... More
